• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY ELUVIA¿ DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY ELUVIA¿ DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number H74939295601570
Device Problems Detachment Of Device Component (1104); Fracture (1260); Stretched (1601); Activation, Positioning or Separation Problem (2906)
Patient Problem Device Embedded In Tissue or Plaque (3165)
Event Date 09/13/2017
Event Type  Injury  
Manufacturer Narrative
(b)(4).Device is a combination product.Device evaluated by mfr: the device has not been received for analysis.Upon receipt and completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Event Description
It was reported the stent partially deployed, elongated, and fractured.A crossover approach was used to access the over 70% stenosed target lesion located in the very tortuous and calcified superficial femoral artery (sfa).Pre-dilation was performed with a mustang balloon.A 6x150 75 cm eluvia¿ drug-eluting vascular stent system, sheath, and standard stiff 0.035" wire were selected for use.During the procedure, eluvia deployment was initiated.After half of the stent deployed, the thumbwheel became blocked once the white arrow was visible and deployment could not be completed with the pull grip.The physician pulled the handle firmly to withdraw the whole system.The device was removed.The stent elongated and fractured.The 15 cm of the stent was removed blocked inside the delivery sheath and 2 cm remained in the patient.A broken inner shaft was also observed.Kinks were observed on the shaft after use.There were no further patient complications and the patient was ok though needed to be re-treated the following day.
 
Manufacturer Narrative
Device evaluated by mfr.: returned product consisted of an eluvia self-expanding stent delivery system (sds) with a.014 guidewire stuck in the device.The outer shaft, mid-shaft, proximal liner and the remainder of the device were checked for damage.The device showed a.014 guidewire stuck inside.The guidewire was protruding from the distal end approximately 58cm and protruding from the proximal end 146cm.Visual examination showed that the outer sheath showed a kink at the nosecone.The mid-shaft showed damage in the form of flattening approximately 4cm from the distal end of the outer sheath distally 21cm to the tip.The pull rack was locked in the handle.The thumbwheel was difficult to turn.The handle was opened for further investigation.The proximal inner and inner liner showed prolapsing damage.The pull rack showed damage on the 1st tooth.The thumbwheel showed blue residue from the pull rack and there was some slight damage.The stent was not returned with the device; however, photos provided from the customer site did confirm that the stent was fractured and damaged.Inspection of the remainder of the device, apart from the observed damage, revealed no other damage or irregularities.The most probable cause of the reported difficulties may be due interaction with another device.The eluvia dfu states that a stiff 0.035 in guidewire is strongly recommended for deployment of the stent, especially for tortuous anatomy and contralateral approaches.Use of undersized guidewires may lead to insufficient support of the device which can compromise stent delivery.(b)(4).
 
Event Description
It was reported the stent partially deployed, elongated, and fractured.A crossover approach was used to access the over 70% stenosed target lesion located in the very tortuous and calcified superficial femoral artery (sfa).Pre-dilation was performed with a mustang balloon.A 6x150 75 cm eluvia drug-eluting vascular stent system, sheath, and standard stiff 0.035" wire were selected for use.During the procedure, eluvia deployment was initiated.After half of the stent deployed, the thumbwheel became blocked once the white arrow was visible and deployment could not be completed with the pull grip.The physician pulled the handle firmly to withdraw the whole system.The device was removed.The stent elongated and fractured.15 cm of the stent was removed blocked inside the delivery sheath and 2 cm remained in the patient.A broken inner shaft was also observed.Kinks were observed on the shaft after use.There were no further patient complications and the patient was ok though needed to be re-treated the following day.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA¿ DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key6926858
MDR Text Key88861144
Report Number2134265-2017-09728
Device Sequence Number1
Product Code NIU
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
SIMILAR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial,Followup
Report Date 09/14/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/07/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/26/2018
Device Model NumberH74939295601570
Device Catalogue Number39295-60157
Device Lot Number20749451
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/05/2017
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/24/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/16/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction Number92169170-FA
Patient Sequence Number1
Patient Outcome(s) Other;
-
-